JIM
REGN icon

Jupiter Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Jupiter Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$17.7M Buy
+28,368
New +$16.1M 0.28% 98
2019
Q4 		– Sell
-44,604
Closed -$12.4M – 498
2019
Q3 		$12.4M Sell
44,604
-56,345
-56% -$16.7M 0.16% 152
2019
Q2 		$31.6M Sell
100,949
-42,596
-30% -$14.2M 0.32% 93
2019
Q1 		$58.9M Buy
143,545
+69,810
+95% +$28.7M 0.54% 60
2018
Q4 		$27.5M Buy
73,735
+34,314
+87% +$12.6M 0.24% 102
2018
Q3 		$15.9M Sell
39,421
-52,546
-57% -$20M 0.11% 138
2018
Q2 		$31.7M Sell
91,967
-548,856
-86% -$172M 0.23% 103
2018
Q1 		$221M Buy
640,823
+391,788
+157% +$136M 1.76% 15
2017
Q4 		$93.6M Sell
249,035
-76,320
-23% -$30.9M 0.86% 42
2017
Q3 		$145M Buy
325,355
+325,290
+500,446% +$155M 1.52% 20
2017
Q2 		$31K Sell
65
-93,938
-100% -$41.1M ﹤0.01% 376
2017
Q1 		$36.4M Buy
94,003
+77,801
+480% +$28.8M 0.51% 64
2016
Q4 		$5.95M Sell
16,202
-248,199
-94% -$94.4M 0.1% 139
2016
Q3 		$106M Buy
264,401
+153,203
+138% +$61.5M 1.84% 14
2016
Q2 		$38.8M Sell
111,198
-3,875
-3% -$1.49M 0.73% 43
2016
Q1 		$41.5M Buy
115,073
+67,300
+141% +$27.7M 0.85% 29
2015
Q4 		$25.9M Buy
47,773
+32,239
+208% +$17.5M 0.69% 50
2015
Q3 		$7.22M Buy
15,534
+5,487
+55% +$2.95M 0.2% 116
2015
Q2 		$5.13M Buy
10,047
+9,653
+2,450% +$4.71M 0.15% 103
2015
Q1 		$177K Buy
+394
New +$167K 0.01% 294
2014
Q1 		– Sell
-14,697
Closed -$4.04M – 401
2013
Q4 		$4.04M Buy
+14,697
New +$4.23M 0.34% 94

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jupiter Investment Management's REGN Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2020: 28,368 shares worth $17.7M. The stake represents 0.28% of the portfolio and ranks #98 among its holdings. This is a return to the name: Jupiter Investment Management previously reported a position in REGN as recently as Q3 2019.

Jupiter Investment Management first reported a position in REGN in Q4 2013 and has held it in 21 quarters since. The position peaked at $221M in Q1 2018. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Jupiter Investment Management held 28,368 shares of Regeneron Pharmaceuticals worth $17.7M as of Q2 2020.
  • Regeneron Pharmaceuticals was a new Jupiter Investment Management position in Q2 2020.
  • Regeneron Pharmaceuticals made up 0.28% of Jupiter Investment Management's portfolio in Q2 2020, its #98 holding.
  • Jupiter Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 21 quarters since.
  • Jupiter Investment Management's Regeneron Pharmaceuticals position peaked at $221M in Q1 2018.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.